Hope Shines Blue for International Angelman Day

Illuminating the Towers in support of the Angelman community

On Sunday 15 February 2026, International Towers Sydney will illuminate the towers in blue in recognition of International Angelman Day.

Each year on 15 February, the global Angelman community comes together to raise awareness, support research and education, inspire action and honour those who are no longer with us. In 2026, the theme Hope Shines Blue reminds us that every light, every story and every act of support contributes to meaningful progress.

Blue is the colour of Angelman syndrome. When landmarks across the world light up in blue, it represents more than awareness. It represents hope for breakthroughs, hope for treatment advances and hope for a brighter future for every individual and family living with Angelman syndrome.

Angelman syndrome is a rare neurogenetic condition affecting approximately 1 in 15,000 people, or around 500,000 individuals worldwide. It is caused by a genetic difference on chromosome 15, resulting in little or no production of the UBE3A protein, which plays a critical role in brain function. As a result, children and adults with Angelman syndrome often experience balance and motor challenges, seizures, communication difficulties and significant sleep disruption. Most individuals require lifelong care and are unable to live independently.

However, scientific progress is accelerating. Researchers believe Angelman syndrome may now be one of the neurogenetic conditions with the greatest potential for transformative treatment. Gene therapy trials are underway, and clinical studies are actively recruiting, marking a pivotal moment for families and the research community.

International Angelman Day invites communities to wear blue, share stories, light up landmarks and support organisations advancing research and care. In Australia, support and advocacy are led by organisations including the Foundation for Angelman Syndrome Therapeutics Australia (FAST Aus), which funds research and clinical programs, and the Angelman Syndrome Association Australia, which provides family support and community services.

By lighting the towers blue, we stand alongside families, researchers and advocates working toward progress. Together, we help shine a light on awareness, research and hope.